Ludmila Muronova

7PUBLICATIONS
48CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical bacteriologyMedical mycologyPredictive and prognostic markersRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 19, 2026
Anti-BCMA immunotherapies deplete plasmacytoid dendritic cells and impair antiviral immunity in multiple myeloma.

|Dec 17, 2025
Selective B-cell subset depletion underlies increased infection risk in patients with MM treated with anti-BCMA vs anti-GPRC5D bsAbs.

Tomas Jelinek, David Zihala, Aintzane Zabaleta

|Nov 14, 2025
Composition and Functional State of T and NK Cells in the Extramedullary Myeloma Tumor Microenvironment.

Anjana Anilkumar Sithara, Veronika Kapustova, David Zihala

|Sep 25, 2025
Elevated circulating tumor cells reflect high proliferation and genomic complexity in multiple myeloma.

Juan-Jose Garces, Benjamin Diamond, Tereza Sevcikova

|Jan 15, 2025
Level of Clonal Plasma Cells in Hematopoietic Cell Autografts Reflects the Pre-Transplant Bone Marrow Minimal Residual Disease in Multiple Myeloma Patients.

Ondrej Venglar, Eva Radova, David Zihala

|Dec 23, 2024
One Year Duration of Immune Response Following a 3rd Booster Dose of mRNA Vaccine Against COVID-19 in 292 Patients With Hematological Malignancies in University Hospital Ostrava, Czech Republic.

Ondrej Šušol, Barbora Šušolová, Ondřej Klempíř

Pageof 2

Frequent Collaborators

3 joint publications

Roman Hajek

3 joint publications

Tereza Popková

3 joint publications

Ondrej Venglar

3 joint publications

Tomas Jelinek